There's a huge thing about RU on this other forum, I'll put the best bits, and dude it looks properly safe.. if it is I am going to swap spironolactone for it, no question.
I'm still looking into underlying things like thyroid, but dude I am not willing to lose any hair in the process lol - pulling out the big guns!!
From the original 1994 paper in France, courtesy of El Duterino:
"As far as RU 58841 is concerned, two principal
metabolites have been identified: RU 56279, resulting
from N-dealkylation and RU 59416, the acid formed by
oxidation of the butyl alcohol function. RU 56279 is
formed in a very low proportion, representing about 1%
of RU 58841 administered, compared with RU 59416,
which represents 93%. RU 58841, a topically active
compound has little systemic activity. Its metabolites
were therefore administered s.c. so as to mimic the
complete passage of the compounds through the skin
and to measure their effects at the level of the prostate
and seminal vesicles. In these conditions, RU 56279
causes an important reduction in prostate and seminal
vesicle weights (as after oral administration). RU 59416
on the other hand does not significantly modify these
parameters. Furthermore, it displays a very low affinity
for the androgen receptor (preliminary results, not yet
published). Thus the lack of systemic effects of RU
58841 could be explained by the fact that it is metabolized
principally to a compound which is inactive on
accessory sex organ weight in the rat.
Thus, the dissociation of the effects RU 56187 and
58841 would therefore seem to be related to the extent
of their metabolism and to the proportion of the common
N-desalkyl metabolite formed.
RU 58841 being at present in clinical development
for the local treatment of acne, alopecia and hirsutism,
its pharmacokinetics have also been studied after
cutaneous administration. The same metabolites were
found in the plasma but at concentrations much
lower than after i.v. administration. These results
showing that RU 58841 is transformed primarily into an
inactive metabolite suggest that, provided that its
metabolism in man is the same as in the rat, it could be
used topically without the risk of affecting accessory sex organ weight."
The thread goes on to talk about other studies, the selling of the patents from company to company and many safe trials of it in humans and animals. It looks very, very safe to me
In fact hell it looks safer than things like finasteride and Flutamide, at least at the moment!
Apparently it's potency topically is equal or superior to finasteride.
The systemic absorption of it also seems to be pretty small, a fraction of that of something like flutamide.
I think we need as many studies of RU as possible, it deserves to be the next spironolactone IMO